RH

Rob Hart

Director at Promptly Patient Experience Suite

Miami, Florida

Overview

Work Experience

  • Partner

    2007 - Current

    Life science and health technology venture capital, growth equity and mission-driven company building

  • Director

    2024

    Web-based patient experience and automation suite for medical practices

  • Founding Investor, Director

    2024

    Cells as reagents

  • Director

    2023

    Providing rural market access to exceptional mental healthcare

  • Director

    2023

    Home-based, community and remote health care for those in need

  • Director

    2020

    Specialty and generic pharmaceuticals, re-shoring

  • Director

    2019

    Peptide drug discovery

  • Director

    2019

    Safeguarding patients through monitoring compliance IT/hardware

  • Director

    2017 - 2023

    Unlocking power of NGS for human identification. Acquired by Qiagen (NYSE:QGEN)

  • Secretary and Board Observer

    2019 - 2022

    Rapid antibiotic susceptibility testing. Acquired by bioMérieux S.A. (ENXTPA:BIM)

Latest Articles

MediumJul. 2017

Creampuff

Talks about Short Story, Short Fiction and Mystery

Relevant Websites